1 / 1

Advancements in Cell Therapy & GMP Manufacture: Insights from the AMC Technical Meeting

Join us as we explore key insights from the AMC Technical Meeting held on September 1, 2011. Experts like Michael Whitaker, Sarah Callens, Bo Kara, and Malcolm Rhodes presented valuable information on GMP manufacture readiness, cell therapy scale-up, and lessons learned in therapeutic protein manufacture. This meeting also featured discussions on available processing technologies in the industry, breakout sessions focused on community needs, and a virtual tour of the Newcastle Biomanufacturing Facility.

pepin
Télécharger la présentation

Advancements in Cell Therapy & GMP Manufacture: Insights from the AMC Technical Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AMC Technical Meeting 1st September 2011 11.00 Welcome and introductions Michael Whitaker, Newcastle Biomedicine 11.15 Are you ready for GMP manufacture? Sarah Callens, eXmoorPharma Concepts 11.35 Cell therapy scale up Bo Kara, Fujifilm Diosynth Biotechnologies 11.55The evolution of therapeutic protein manufacture: Lessons for cell therapy manufacture Malcolm Rhodes, HealthTech and Medicines KTN 12.15 Experiences in scale up of a cell therapy SowmyaViswanathan, Princess Mary Hospital, Toronto 12.15 Cell therapy processing technologies What is available from industry? 13.15 LUNCH 14.15 Cell therapy processing technologies break out sessions What the community wants from processing technologies 15.45 Break out session presentations 16.15 Newcastle Biomanufacturing Facility virtual tour Mark Lowdell, UCL 16.45 Close of Day Chris Mason, UCL

More Related